Mad Money: Key points from April 13, 2021 (Tuesday) episode

This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, April 13, 2021.  It also contains links to CNBC sites which contain video clips and transcripts are also listed.

(1) After trimming charitable holdings, Cramer reveals 7 stock market concerns going into earnings season (https://www.cnbc.com/2021/04/13/jim-cramer-reveals-7-stock-market-concerns-going-into-earnings-season.html)

• “I’m not a bear, but there are legitimate concerns here, which is why we sold a bunch of stock for my charitable trust on the eve of that conference call I gave last week,” CNBC’s Jim Cramer said.
• “This market can handle one or even two of these potential problems, but it can’t handle all of them,” the “Mad Money” host said.
• Cramer said inflation, rising Covid-19 cases and a shortage in semiconductors are among his top concerns about the current market environment.

(2) [No Video Clip] Voice of Cramerican — Ticker: DKNG [buy a little now], LOGI [continue to do goo, take out cost base], BAC [Hold on], MAT [can go higher. take a cost base]

(3) Cramer calls Coinbase the ‘real deal,’ but warns investors to brace for a bumpy ride with the stock (https://www.cnbc.com/2021/04/13/cramer-calls-coinbase-the-real-deal-warns-of-bumpy-ride-with-stock.html)

• CNBC’s Jim Cramer recommended buying Coinbase shares at the right price when it opens for trading on Wednesday.
• “I think Coinbase is the real deal — the numbers are incredible — but I hate the timing,” the “Mad Money” host said.
  Investors should start a position in Coinbase below $475 and double down on the stock on a decline, he said.

Ticker: COIN

(4) Executive Interview: Novocure exec chairman on studying Tumor Treating Fields (https://www.cnbc.com/video/2021/04/13/novocure-exec-chairman-on-studying-tumor-treating-fields.html)

Novocure Executive Chairman Bill Doyle discussed studying Tumor Treating Fields, electric fields that disrupt cancer cell division, in stage 4 non-small cell lung cancer.

Ticker: NVCR

(5) Cramer’s lightning round: I like Coinbase and I like CME Group (https://www.cnbc.com/2021/04/13/cramer-lightning-round-i-like-coinbase-and-i-like-cme-group.html)

• Regeneron Pharmaceuticals: “It’s time for the NIH and the CDC to get their act together and start pushing what [CEO] Leonard Schleifer and Dr. [George] Yancopoulos have, which is something that gets you out of the hospital very quickly. I am getting very angry at them. They should be playing ball and helping people.”
• Bumble: “I am a believer.”
• CME Group: “I’m going to give you a twofer: I like Coinbase and I like CME.”
• Plug Power: “I need to get to the bottom of the accounting irregularities.”
• Karuna Therapeutics: “It’s a decent speculation. I would have a little bit on.”
• Weyerhaeuser: “You can hold it, but I do worry that that particular commodity, if we make a deal with cannabis, is going to go lower.”
• Aphria: “That last quarter was not what I wanted. [CEO] Irwin Simon is good, but that was not a great quarter. I think if it gets a pop on the finish of the merger, sell.”

Ticker: REGEN, BMBL, CME, PLUG, KRTX, WY, AP

(6) [No Video Clip] Where the young inventor goes

Other Stocks discussed (calls with audiences):Brunswick Corporation (BC) [Cramer: sell], Barrick Gold Corporation (GOLD) [Cramer: hold 5% of assets as gold and 5% in Bitcoin]

Ref: Links to other sites that relate to episode of April 13, 2021.

• Google Podcast (Sounds）
• Internet Archive (Video & Texts per minute）

Disclaimer

****************************